Test Menu - Haemato Oncology

LIS - Code Test Name Test Methodology Specimen Type Container Volume Temperature / Transport TAT Cut off Test Requistion form Status/ Remarks/comments Test Components
PCR - MH001 BCR-ABL1 (IS) by Real-time PCR Real time PCR Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 24 hours of collection at refrigerated temperature to prevent RNA degradation
Detailed history regarding diagnosis, treatment and drug administration along with dose esclation if any must be provided. .
Hemato-Oncology TRF required and present CBC report and past BCRABL1 reports of followup patients if any
3 days Sample by 2:00 PM   This test is designed for monitoring response to TKI therapy in p210(e13a2 or e14a2) transcript positive CML. Synonym is BCR-ABL1 Quantitative. This test is not advisable to be requested at initial diagnosis as it detects only p210 type of transcripts and not other rare varieties of transcripts. A negative result by this at diagnosis does not rule out CML. BCR-ABL1 copies, ABL1 copies, Normalised copy number, International Scale Normalised Copy number ONLY for p210(e13a2 or e14a2) transcripts. DOES NOT DETECT OTHER TRANSCRIPTS
G2232 BCR-ABL1 Qualitative Multiplex for Detection of Transcript Reverse transcription PCR Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 24 hours of collection at refrigerated temperature to prevent RNA degradation
Detailed history regarding diagnosis, treatment and drug administration along with dose escalation if any must be provided. .
Hemato-Oncology TRF required and present CBC report and past BCRABL1 reports of followup patients if any
3 days Sample by 2:00 PM Initial diagnosis of patients suspected to be suffering from CML, ALL, AML or Mixed Phenotype Acute Leukaemia for the presence of the BCR-ABL1 fusion.
This test is not designed for molecular monitoring of a diagnosed patient as it can give false negative when fusion copies are present at a low level
Presence or absence of e13a2, e14a2, e1a2, e19a2 as well as detection of rare transcripts. Presence or absence of control gene.
G2127 JAK2 V617F Mutation Study by Real-time PCR (V617F) Real time PCR Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Relevant clinical history needs to be provided including CBC findings, bone marrow findings if available, clinical features and indication for performing JAK2 V617F analysis. If JAK2 V617F has been already performed at another location, then please provide the report. 2 days Sample by 2:00 PM This test is designed to detect only the common variety of JAK2 mutation i.e. V617F mutation. This is performed at high sensitivity which also detects low allele burden JAK2 which are present at <20% VAF. This test does not detect mutations of JAK2 gene other than V617F for which JAK2 mutation panel is to be ordered Presence or absence of JAK2 V617F mutation
MH002 JAK2 Mutation Panel (Exons 12 to 15) Next Generation Sequencing Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Relevant clinical history needs to be provided including CBC findings, bone marrow findings if available, clinical features and indication for performing JAK2 V617F analysis. If JAK2 V617F has been already performed at another location, then please provide the report. 10 days Sample by 2:00 PM This test detects presence of JAK2 mutations in exons 12 to 15 of JAK2 which helps to detect presence of rare JAK2 mutations including as well as other than JAK2 V617F mutations found in Polycythaemia Vera. Presence or absence of JAK2 V617F mutation as well as presence or absence of JAK2 mutations in exons 12 to 15 of JAK2.
MH004 Onco haem (DNA+RNA) (AML and B-ALL By NGS) Next Generation Sequencing Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 48 hours of collection at refrigerated temperatureto prevent RNA degradation
Detailed history regarding clinical features, CBC, bone marrow findings, immunphenotyping, cytogenetics and/or other investigation results available must be provided. Information about suspected diagnosis is mandatory
10 days Sample by 2:00 PM There are 40 key DNA target genes and 29 driver genes in a broad fusion panel to cover all the major myeloid disorders and several acute lymphoid disorders. Can be ordered in the following disorders: Myeloproliferative neoplasm panel(MPN panel)
Acute myeloid leukaemia panel(AML panel)
Acute lymphoblastic leukaemia (ALL panel)
Myelodysplastic syndrome panel (MDS panel)
Chronic myeloid leukaemia (CML)
Chronic myelomonocytic leukaemia (CMML)
Juvenile myelomonocytic leukaemia (JMML)
Other myeloid disorders
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NPM1, NRAS, PTPN11, SETBP1, SF3B1, SRSF2, U2AF1, WT1. Full Genes: ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2. Fusion Driver Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6 (TEL), FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A(MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM16, RUNX1 (AML1), TCF3(E2A), TFE3
T4516 Onco haem: DNA only by NGS Next Generation Sequencing Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 48 hours of collection at refrigerated temperatureto prevent RNA degradation
Detailed history regarding clinical features, CBC, bone marrow findings, immunphenotyping, cytogenetics and/or other investigation results available must be provided. Information about suspected diagnosis is mandatory
10 days Sample by 2:00 PM There are 40 key DNA target genes to cover all the major myeloid disorders and several acute lymphoid disorders. Can be ordered in the following disorders: Myeloproliferative neoplasm panel(MPN panel)
Acute myeloid leukaemia panel(AML panel)
Myelodysplastic syndrome panel (MDS panel)
Chronic myeloid leukaemia (CML)
Chronic myelomonocytic leukaemia (CMML)
Juvenile myelomonocytic leukaemia (JMML)
Other myeloid disorders
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NPM1, NRAS, PTPN11, SETBP1, SF3B1, SRSF2, U2AF1, WT1. Full Genes: ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2. Fusion Driver Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6 (TEL), FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A(MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM16, RUNX1 (AML1), TCF3(E2A), TFE3
T4517 Onco haem: RNA only by NGS Next Generation Sequencing Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 48 hours of collection at refrigerated temperatureto prevent RNA degradation
Detailed history regarding clinical features, CBC, bone marrow findings, immunphenotyping, cytogenetics and/or other investigation results available must be provided. Information about suspected diagnosis is mandatory
10 days Sample by 2:00 PM There are 29 driver genes in a broad fusion panel to cover all the major myeloid disorders and several acute lymphoid disorders. Can be ordered in the following disorders: Myeloproliferative neoplasm panel(MPN panel)
Acute myeloid leukaemia panel(AML panel)
Acute lymphoblastic leukaemia (ALL panel)
Myelodysplastic syndrome panel (MDS panel)
Chronic myeloid leukaemia (CML)
Chronic myelomonocytic leukaemia (CMML)
Juvenile myelomonocytic leukaemia (JMML)
Other myeloid disorders
Fusion Driver Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6 (TEL), FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A(MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM16, RUNX1 (AML1), TCF3(E2A), TFE3
T2256 Chimerism Study Fragment Length Analysis (STR based). Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Following details must be provided: Test name, Patient’s Name; Donor’s Name; their: age, gender, relation, blood group; Clinician's name and Contact number; Collection person's name; Transplant type; Disease; Sample type - EDTA peripheral blood or Bone Marrow. 4 days Sample by 2:00 PM Testing consists of a panel of 24 STR markers with allele sizes that differ among individuals D3S1358, vWA, D16S539, CSF1PO, TPOX, Yindel, AMEL, D8S1179, D21S11, D18S51, DYS391, D2S441, D19S433, TH01, FGA, D22S1045, D5S818, D13S317, D7S820, SE33, D10S1248, D1S1656, D12S391, D2S1338
T2552 Imatinib Resistance Mutation Analysis Next Generation Sequencing Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 48 hours of collection at refrigerated temperature to prevent RNA degradation
Detailed history regarding diagnosis, treatment and drug administration along with dose esclation if any must be provided. .
Hemato-Oncology TRF required and present CBC report and past BCRABL1 reports of followup patients if any
14 days Sample by 2:00 PM Detects common as well as rare missense mutations present in ABL1 region of BCR-ABL1 fusions present in the patients in exons 4 to exons 10 of ABL1 gene Presence of common as well as rare missense mutations present in ABL1 region of BCR-ABL1 fusions present in the patients in exons 4 to exons 10 of ABL1 gene
G2125 PML-RARA Fusion Gene Detection (Qualitative) Reverse transcription PCR Whole Blood or Bone Marrow Purple / Lavender Top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 24 hours of collection at refrigerated temperature to prevent RNA degradation
Detailed history regarding diagnosis, treatment and drug administration along with dose esclation if any must be provided. .
Hemato-Oncology TRF required and present CBC report and past PMLRARA reports of followup patients if any
3 days Sample by 2:00 PM Initial diagnosis of patients suspected to be suffering from APML for the presence of PMLRARA fusion.
This test is not designed for molecular monitoring of a diagnosed patient as it can give false negative when fusion copies are present at a low level. Urgency of the test must be informed to the laboratory before sending the sample.
Presence or absence of bcr1, bcr2 or bcr3 transcripts in PMLRARA
G1955 PML-RARA Fusion Gene Detection (Quantitative) Reverse transcription PCR for bcr2; Real time PCR for bcr1 and bcr3 Whole Blood or Bone Marrow Purple / Lavender top EDTA 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens must be received within 24 hours of collection at refrigerated temperatureto prevent RNA degradation
Detailed history regarding diagnosis, treatment and drug administration along with dose esclation if any must be provided. .
Hemato-Oncology TRF required and present CBC report and past PMLRARA reports of followup patients if any
3 days Sample by 2:00 PM This test is designed for monitoring response to therapy in patients initially diagnosed as APML. It is required to mention the transcript type at diagnosis to avoid discrepancies. Here, bcr2 transcript detection is performed qualitatively and not quantitatively. Urgency of the test must be informed to the laboratory before sending the sample. Presence or absence of bcr2. Quantitative detection of bcr1 and bcr3. Please note that this is not reported on international scale and hence this may not be correlated with other labs.
CYTOGENETICS- HEMATOONCOLOGY
T1610 Karyotyping From Bonemarrow Culture Karyotyping Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3ml whole blood/ 2ml bone marrow aspirate 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 24 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM TRF Required with clinical history Karyotype
T2493 Del(5q) By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM Deletion 5q
T2494 Del(7q) By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM Deletion 7q
CY12 Del(20q) By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM Deletion 20q
CY02 E2A/TCF3 Detection By FISH Fluorescence In Situ Hybridization Whole blood or bone marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM E2A/TCF3 rearrangement
T2501 IgH By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM IGH rearrangement
CY03 INV 16 By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM CBFB-MYH11 fusion
CY10 TEL-AML By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM ETV6-RUNX1 fusion
CY01 AML1-ETO By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM AML-ETO fusion, RUNX1-RUNX1T1 fusion
T2495 MLL By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM KMT2A /MLL rearrangement
T2497 11q (ATM) By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM deletion 11q
T2496 17p (p53) By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM deletion 17p
T2498 PDGFR Alpha By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM PDGFRA rearrangement
T2499 PDGFR Beta By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM PDGFRB rearrangement
T2480 PML-RARA Detection By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM PML, RARA fusion
T1604 BCR-ABL1 By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM BCR-ABL1 fusion
CY11 Trisomy 8 By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM trisomy 8
T2519 ALL Panel By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM E2A/TCF, MLL/KMT2A, BCR-ABL1, TEL-AML/ETV6-RUNX1
T2521 AML Panel By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM Inv16(CBFB-MYH11), PML-RARA, MLL/KMT2A, AML-ETO(RUNX1-RUNX1T1)
T2518 CLL Panel By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM ATM/TP53(17p deletion, 11q deletion), DLEU(13q deletion), trisomy 12
T2335 MDS Panel By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM 5q,7q,20q
T2522 MM Panel By FISH Fluorescence In Situ Hybridization Whole Blood / Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 7 days Sample by 2:00 PM 17p deletion, IGH rearrangement(t(11;14), t(14;20), t(4;14), 1q amplification, 1p deletion, 13q deletion
T3457 Stress Cytogenetics Karyotyping Sodium Heparin Blood Green color top 3 vials of 3ml each 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 24 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 12 days Sample by 2:00 PM
CY05 MYEOV/IGH By FISH t(11;14) Fluorescence In Situ Hybridization Whole Blood or Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade 5 days Sample by 2:00 PM MYEOV, IGH
T3882 BCL2/IGH (Follicular lymphoma) By FISH Fluorescence In Situ Hybridization Whole Blood or Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM BCL2, IGH
T3900 BCL-6 By FISH Fluorescence In Situ Hybridization Whole Blood or Bone Marrow Sodium Heparin (Green Top) 3 to 5 mL whole blood or 2 mL bone marrow. 2 to 8 Degree Centrigrade Specimens should arrive in the laboratory within 48 hours of collection. Indicate date and time of collection on test request form. Sample should be collected in sterile atmosphere. Do not open top of the vial while transferring the sample. 5 days Sample by 2:00 PM BCL6

Accreditations

CLIA No. 34D2205781